FDA Import Refusal 224-4713484-6/1/1 — Sato Pharmaceutical Co., Ltd
The FDA refused shipment 224-4713484-6/1/1 from Sato Pharmaceutical Co., Ltd (Japan) on August 31, 2016. The refused product falls under Drugs and Biologics — MECLIZINE HCL (ANTI-EMETIC/NAUSEANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- August 31, 2016
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 61TAA11 MECLIZINE HCL (ANTI-EMETIC/NAUSEANT)
- Charges
- 75